Dr. Vladimir Katanaev

Scientific Director

Email

vkatanaev@hbku.edu.qa

Dr. Vladimir Katanaev

Scientific Director

Educational Qualifications

Dr.Habil in Cell and Developmental Biology

PhD in Biochemistry

Entity

Qatar Biomedical Research Institute

Division

Translational Oncology Research Center

Biography

Dr. Vladimir Katanaev is the Scientific Director of the Translational Oncology Research Center at the Qatar Biomedical Research Institute. He leads efforts to bridge basic, translational, and clinical research, focusing on developing targeted therapies for cancer patients. He is committed to advancing the understanding of fundamental cellular mechanisms, exploring how their dysfunction contributes to disease, and translating this knowledge into innovative therapeutic strategies. Dr. Katanaev has made significant contributions to the field through his research on signal transduction pathways and their implications in cancer and other diseases. His work has been widely recognized and published in leading scientific journals.

Dr.Habil in Cell and Developmental Biology

University of Konstanz, Germany

2010

PhD in Biochemistry

University of Fribourg, Switzerland

2000

Diploma with Honors in Biochemistry

Krasnoyarsk State University ( Siberian Federal University), Russia

1994

  • Oncogenic signaling pathways
  • Anticancer drug discovery and development
  • Precision oncology
  • Breast cancer

Scientific Director

Qatar Biomedical Research Institute, Hamad Bin Khalifa University

2024 - Present

Full Professor and Chair

Faculty of Medicine, University of Geneva, Switzerland

2018 - 2024

Associate Professor

Pharmacology and Toxicology, University of Lausanne, Switzerland

2011 - 2018

Junior Group Leader

Faculty of Sciences, University of Konstanz, Germany

2005 - 2011

Associate Research Scientist

Genetics and Development, Columbia University, United States

2003 - 2005

Postdoctoral Fellow

Genetics and Development, Columbia University, United States

2000 - 2003

Ham, H., Jing, H., Lamborn, I., Kober, M. M., Koval, A., Berchiche, Y., Anderson, D. E., Druey, K. M., Mandl, J. N., Isidor, B., Ferreira, C. R., Freeman, A. F., Ganesan, S., Karsak, M., Mustillo, P. J., Teo, J., Zolkipli-Cunningham, Z., Chatron, N., Lecoquierre, F., ... Su, H. C. (2024). Germline mutations in a G protein identify signaling cross-talk in T cells. Science, 20, eadd8947.

Li, Y., Chen, F., Shen, W., Li, B., Zheng, N., Lu, Y., Katanaev, V. L., & Jia, L. (2021). Nucleolar protein 7 facilitates melanoma progression and metastasis. Signal Transduction and Targeted Therapy, 6, 352.

Kryuchkov, M., Bilousov, O., Lehmann, J., Fiebig, M., & Katanaev, V. L. (2020). Reverse and forward engineering of Drosophila corneal nanocoatings. Nature, 585, 383–389.

Keshelava, A., Solis, G. P., Hersch, M., Koval, A., Kryuchkov, M., Bergmann, S., & Katanaev, V. L. (2018). High capacity in G protein-coupled receptor signaling. Nature Communications, 9, 876.

Solis, G. P., Bilousov, O., Lüchtenborg, A. M., Koval, A., Lin, C., & Katanaev, V. L. (2017). Golgi-resident Gαo promotes protrusive membrane dynamics. Cell, 170, 939–955.

Complete Publication Listing(s): PubMed

  • 2023; 3R Award of the University of Geneva.
  • 2021; Academician of the International Eurasian Academy of Sciences (European Center).
  • 2019; One Hundred Talent Program, Fuzhou City, China.
  • 2019; One Hundred Talent Program, Fujian Province, China.
  • 2018; Chair in Translational Oncology, Faculty of Medicine, University of Geneva.